Charities Ensnared In NJ Antitrust Suit Over Cancer Drugs
By Jeannie O'Sullivan · February 22, 2022, 4:29 PM EST
Two nonprofits have been added to a sweeping antitrust lawsuit accusing Celgene Corp. and parent Bristol-Myers Squibb Co. of stifling generic competition for two blockbuster cancer drugs and driving up prices...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login